The most prevalent abnormality was gonadotropin-independent precocious puberty (GIPP) in eight patients (62%), followed by growth hormone (GH) excess and hyperprolactinaemia in three patients, respectively (23%), and thyrotoxicosis in two (15%) (Table 1). This evidence concerns the gene GH1 and peripheral precocious puberty.